• Jorge Adrián Dolab, Adolfo Rafael de Roodt, Ernesto Horacio de Titto, Susana Isabel García, Raúl Funes, Oscar Danie Salomón, and Jean-Philippe Chippaux.
• Departamento de Vacunas y Sueros, INPB-ANLIS 'Dr Carlos G. Malbrán', Ministerio de Salud, Argentina.
• Trans. R. Soc. Trop. Med. Hyg. 2014 May 1; 108 (5): 269-76.

BackgroundThe incidence and case fatality rate of snakebite in Argentina are poorly known.MethodsThe authors used questionnaires provided with antivenoms by the primary manufacturer of anti-venoms in Argentina.ResultsA total of 8083 completed questionnaires was collected between 1978 and 1998. The annual incidence of snakebite was 1.8 bites per 100,000 inhabitants, with a high geographical heterogeneity; in the northern provinces of the country, the incidence can exceed 150 snakebites per 100,000 people per year. Bothrops (pit viper) bites predominated, accounting for 96.6% (6720/6957) of envenomations, bites from Crotalus (rattlesnake) accounted for 2.8% (195/6957), and bites from Micrurus (coral snake) for 0.6% (42/6957). Most patients were young men, who were generally bitten during agricultural activities, i.e. while working in the fields. Most snakebites (78.9%, 5852/7419) were to the lower limb, including 58.3% (4322/7419) to the foot. The case fatality rate was <0.04% (3/8083). Most envenomations (90%, 7275/8083) were treated with specific antivenom during the first 4 h after the bite. The median dose of antivenom was two vials for viper bites (Bothrops and Crotalus) and three vials for Micrurus bites.ConclusionThese preliminary results should enable manufacturers to increase the availability of appropriate antivenom and health authorities to improve the management of snakebites where they are most common.

25 keywords...

hide…